|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: AXYS PHARMECUETICALS INC, 10-Q, EX-10.127, 2000-08-14 |
Next: CNL INCOME FUND XV LTD, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS, STATEMENTS OF OPERATIONS AND STATEMENTS OF CASH
FLOWS INCLUDED IN THE COMPANY'S FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2000,
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS AND
NOTES THERETO.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> JUN-30-2000
<CASH> 30,932
<SECURITIES> 8,578
<RECEIVABLES> 630
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 43,919
<PP&E> 43,226
<DEPRECIATION> (28,770)
<TOTAL-ASSETS> 98,444
<CURRENT-LIABILITIES> 31,810
<BONDS> 0
0
0
<COMMON> 326,532
<OTHER-SE> 64,340
<TOTAL-LIABILITY-AND-EQUITY> 98,444
<SALES> 619
<TOTAL-REVENUES> 3,505
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 25,659
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 531
<INCOME-PRETAX> (21,145)
<INCOME-TAX> 0
<INCOME-CONTINUING> (21,145)
<DISCONTINUED> 34,048
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 12,903
<EPS-BASIC> (0.38)
<EPS-DILUTED> (0.38)
</TABLE>
|
|